In light of the recent statement made by the European Food Safety Authority (EFSA):
ACI is aware of the recent statement from EFSA regarding novel food applications which lack the data required to make a judgement of safety.
As we are not informed on the content of those individual applications, we are not in a position to comment.
ACI has lodged its recently completed toxicology study in compliance with OECD 408 guidelines with the UK’s Food Standards Agency, and we await feedback in relation to supporting our members NFAs in the UK.
For a more detailed coverage see this article on Cannabinoid Insight – EFSA suspends novel food applications due to ‘data gaps and uncertainties’ .